Cita APA

Thomas, J. S., El-Khoueiry, A. B., Maurer, B. J., Groshen, S., Pinski, J. K., Cobos, E., . . . Newman, E. M. (2021). A Phase I Study of Intravenous Fenretinide (4-HPR) for Patients with Malignant Solid Tumors. Cancer Chemother Pharmacol.

Citación estilo Chicago

Thomas, Jacob S., et al. "A Phase I Study of Intravenous Fenretinide (4-HPR) for Patients With Malignant Solid Tumors." Cancer Chemother Pharmacol 2021.

Cita MLA

Thomas, Jacob S., et al. "A Phase I Study of Intravenous Fenretinide (4-HPR) for Patients With Malignant Solid Tumors." Cancer Chemother Pharmacol 2021.